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Abstract
Background: Antibiotics and proton pump inhibitors (PPIs) are associated with Clostridium difficile infection (CDI).
Both a computer order entry alert to highlight this association as well as antimicrobial stewardship directed
prospective audit and feedback represent novel interventions to reduce the co-administration of antibiotics and
PPIs among hospitalized patients.
Methods: Consecutive patients admitted to two General Internal Medicine wards from October 1, 2010 until March
31, 2013 at a teaching hospital in Toronto, Ontario, Canada were evaluated. The baseline observation period was
followed by the first phase, which involved the creation of a computerized order entry alert that was triggered
when either a PPI or an antibiotic was ordered in the presence of the other. The second phase consisted of the
introduction of an antibiotic stewardship-initiated prospective audit and feedback strategy. The primary outcome
was the co-administration of antibiotics and PPIs during each phase.
Results: This alert led to a significant reduction in the co-administration of antibiotics and PPIs adjusted for month
and secular trends, expressed as days of therapy per 100 patient days (4.99 vs. 3.14, p < 0.001) The subsequent
introduction of the antibiotic stewardship program further reduced the co-administration (3.14 vs. 1.80, p <0.001).
No change was observed in adjusted monthly CDI rates per 100 patient care days between the baseline and alert
cohorts (0.12 vs. 0.12, p = 0.99) or the baseline and antibiotic stewardship phases (0.12 vs. 0.13, p = 0.97).
Conclusions: Decreasing the co-administration of PPIs and antibiotics can be achieved using a simple automatic
alert followed by prospective audit and feedback.
Keywords: Computerized alerts, Antibiotic stewardship, Proton pump inhibitors, Clostridium difficile infection,
Prospective audit and feedback
Background
Hospitalization represents an opportunity to assess
medication appropriateness. Proton pump inhibitors
(PPIs) are frequently inappropriately used and represent
an ideal target for re-evaluation [1, 2]. PPIs increase the
risk of Clostridium difficile infection (CDI), including
both incident episodes as well as recurrences, by approxi-
mately 60 % [3, 4]. This elevated risk exists irrespective of
whether the infection was acquired in a community or
hospital setting [4, 5]. Antibiotics also increase the risk of
nosocomial CDI, particularly when prescribed concur-
rently with a PPI [6–9]. Accordingly, interventions target-
ing a reduction in the co-administration of PPIs and
antibiotics may be beneficial.
Automated alerts activated at the time of computer
order entry (CPOE) have been used to reduce medical
errors through warnings of impending drug-drug inter-
actions and unrecognized drug allergies. Similar inter-
ventions have successfully altered PPI prescribing
patterns in the hospital setting and changed antibiotic
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prescribing patterns [10, 11]. A similar automated strat-
egy may reduce concurrent PPI and antibiotic use, but
this has not yet been tested. Extending the purview of
antibiotic stewardship programs (ASP), which are suc-
cessful in lowering antibiotic use in the acute care set-
ting, to identify medications with the potential to
increase the harms of antibiotics is another potential
intervention to limit co-administration [12].
We evaluated the impact of a real-time automated
computer physician order entry (CPOE) alert followed
by an ASP-initiated prospective audit and feedback
(PAF) strategy on rates of co-administration of PPI’s and




We prospectively evaluated consecutive patients admit-
ted to two General Internal Medicine wards from Octo-
ber 1, 2010 until March 31, 2013 at a 490-bed teaching
hospital in Toronto, Ontario, Canada. The baseline ob-
servation interval occurred from October 1, 2010 until
September 30, 2011. The first phase, from October 1,
2011 until March 31, 2012, involved the implementation
of a CPOE alert that was triggered when either a PPI or
an antibiotic was ordered in the presence of the other.
This alert highlighted the association of concurrent PPI’s
and antibiotics with the increased risk of subsequent
CDI. Embedded within the alert was an educational tool
that assisted with a risk-benefit analysis of whether to
stop a PPI, which for example should be continued in
the setting of a recent upper gastrointestinal bleed. The
second phase consisted of the introduction of an ASP-
initiated PAF strategy, which occurred from April 1,
2012 until March 31, 2013. PAF was triggered from
Monday to Friday when an inpatient was prescribed a
systemic antimicrobial agent. The aim of the ASP was to
provide recommendations regarding the appropriateness
of antimicrobial therapy as well as to note the concomi-
tant use of a PPI. Ethics approval was granted from
Toronto East General Hospital’s Research Ethics Board.
Outcome measures
Inpatient orders of antibiotics and PPIs were obtained
from the computer order entry system (PowerChart,
Cerner Canada, Markham, Canada) and reported as days
of therapy (DOT) for each individual medication per 100
inpatient days. One DOT represents the administration
of a single medication on a given day irrespective of dos-
ing frequency or strength. Hospital-acquired CDI was
confirmed using the Ontario Ministry of Health and
Long Term Care case definition with toxin detection by
enzyme immunoassay or polymerase chain reaction and
presented as a rate over 100 inpatient days [13]. Only
loose stool specimens were processed and repeat testing
of duplicate specimens within seven days was not per-
mitted. The primary outcome was co-administration of
PPI’s and antibiotics. Pre-specified secondary outcomes
consisted of CDI rates, PPI use, antibiotic use, and the
frequency with which the alert was activated. Only the
initial occurrence of the triggered alert for each patient
during each hospitalization was used for analysis. Coun-
tervailing measures included rates of Gastroenterology
consultation and receipt of packed red blood cell trans-
fusion. Transfusions are a marker of acute gastrointes-
tinal bleeding while specialist consultation serves to
highlight the possible need for guidance in treating con-
ditions exacerbated by the abrupt cessation of PPI’s.
Statistical analysis
Generalized linear models were used to analyze system-
atic differences between the three intervention periods
while adjusting for seasonality (monthly effects) and
secular trends. In particular, logistic regression was used
for the binary outcomes (co-administration, antibiotics,
and PPIs), while Poisson regression was used for the
count-based outcomes (rates of CDI, packed red blood
cell transfusions, and Gastroenterology consultations).
For each outcome, we used the Box-Pierce P-value
against the null hypothesis that the errors from the ad-
justed model are uncorrelated. Further, we report the ad-
justed outcome rate for each period (standardized to
events per 100 patient care days), and the Wald Test
P-value against the null hypothesis of ‘no systematic dif-
ference’ for each pair of time periods (Baseline-Alert,
Baseline-Stewardship, and Alert-Stewardship). For the
demographic information collected for each cohort we
used a one-way ANOVA and a two-tailed chi-square test
to assess for differences between continuous and categor-
ical variables, respectively. The analysis was conducted
using R version 3.0.2.
Results
A total of 54,005 inpatient days were included (21,542
baseline, 10,763 CPOE, and 21,700 ASP). The three co-
horts had similar baseline characteristics and discharge
diagnoses, aside from a decrease in the proportion of
patients with a respiratory illness among the ASP cohort
(Table 1). The unadjusted average monthly co-
administration of PPI’s and antibiotics expressed as
DOT per 100 patient days varied between the baseline
(5.76, 95 % confidence interval 4.78-6.73), alert (3.47,
2.83-4.11), and ASP cohorts (2.22, 1.75-2.69) (Fig. 1).
When adjusting for time and month there was a statisti-
cally significant decline in the co-administration of PPIs
and antibiotics between the baseline and alert phases
(4.99 vs. 3.14 DOT per 100 patient days, p < 0.001), the
baseline and ASP phases (4.99 vs. 1.80, p <0.001) and
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the alert and ASP (3.14 vs. 1.80, p <0.001). Antibiotic ad-
ministration significantly declined over each successive
time period from the baseline to the alert and through
the initiation of the ASP (18.98 DOT per 100 inpatient
days, 14.90, and 8.90, respectively), which was mirrored
by a decline in PPIs (33.52, 29.50, and 23.95, respect-
ively) (Fig. 2).
The average monthly frequency of the triggered alert
was 25.5 during the alert cohort and 16.9 (p = 0.002)
during the ASP cohort (Fig. 3). Adjusted monthly CDI
rates per 100 inpatient days did not differ between the
baseline and alert phases (0.12 vs. 0.12, p = 0.99), the
baseline and ASP (0.12 vs. 0.13, p = 0.97) or between the
alert and ASP (0.12 vs. 0.13, p = 0.95). Similarly, no
changes in adjusted monthly packed red blood cell
transfusion rates (1.30 vs. 1.36, p = 0.80) or Gastroenter-
ology consultations (2.69 vs. 2.96, p = 0.42) between the
baseline and alert groups and between the baseline and
ASP cohorts (1.30 vs. 1.18, p = 0.71 and 2.69 vs. 2.16,
p = 0.24, respectively) were observed.
Discussion
We observed a reduction in antibiotic and PPI co-ad-
ministration following the initiation of both an auto-
mated computer order entry alert as well as the
introduction of ASP initiated PAF. The alert led to a
decrease in PPIs and antibiotics that was immediate and
simple to implement. The integration of PPI
optimization to the responsibilities of an ASP afforded
further reductions in co-administration beyond that re-
alized from the alert and allowed for sustainability of
the effect.
Automated alerts can alter PPI prescribing patterns
and may have prompted clinicians to reconsider the util-
ity of PPI’s in the high-risk setting of prescribing antibi-
otics [6, 10]. The alert may have engendered an
additional evaluation of the risk-benefit ratio of prescrib-
ing antibiotics that cumulatively led to the reduction in
antibiotic use observed. Lowering overall antibiotic use
has been associated with a reduced incidence of nosoco-
mial CDI while it is unclear whether a similar benefit oc-
curs with PPIs [14]. The decrease in co-administration
was not associated with a reduction in CDI rates, how-
ever the low overall event rate limited statistical power.
Antibiotic classes variably affect CDI risk yet in the hos-
pital setting cumulative antibiotic exposure is an inde-
pendent risk factor for CDI making it imperative to
target all antibiotics and not restrict the alert to only
those associated with an elevated risk [15, 16]. The
abrupt cessation of a PPI results in rebound acid hyper-
secretion that can potentially exert a protective effect
against contracting C. difficile through an increase in
gastric acidity [17]. The reduction in PPIs did not result
in a change in the rates of red blood cell transfusion or
Gasteroenterology consultation, both of which are rela-
tively crude markers of harm
Table 1 Baseline demographic characteristics for each study cohort
Variable Baseline Computer alert Antibiotic stewardship p value
Age (mean years ± SD) 71.22 ± 17.64 71.10 ± 17.13 72.47 ± 16.67 0.0212
Male sex (%) 45.92 44.36 45.71 0.6706
Patient care days (mean ± SD) 1795.17 ± 116.64 1793.83 ± 92.16 1808.33 ± 115.74 0.9513
Diagnosis at hospital discharge
Blood & lymphatic system 56 (2) 28 (2) 51 (2) 0.9324
Circulatory system 216 (9) 119 (10) 179 (8) 0.0581
Digestive system 310 (14) 175 (15) 299 (13) 0.281
Ear, nose, mouth & throat 21 (1) 16 (1) 24 (1) 0.4354
Endocrine system, nutrition & metabolism 143 (6) 66 (6) 115 (5) 0.2956
Hepatobiliary system & pancreas 171 (7) 95 (8) 182 (8) 0.5827
Kidney, urinary tract & male reproductive system 218 (10) 107 (9) 185 (8) 0.3295
Musculoskeletal system & connective tissue 103 (5) 66 (6) 114 (5) 0.2569
Nervous system 234 (10) 123 (11) 276 (12) 0.0588
Respiratory system 187 (8) 75 (7) 89 (4) <.0001
Skin, subcutaneous tissue & breast 82 (4) 41 (4) 82 (4) 0.9803
Multisystem or unspecified site infections 62 (3) 26 (2) 78 (4) 0.0951
Other 486 (21) 206 (18) 551 (25) <.0001
Unless otherwise specified, data are no. (%) of patients
Abbreviations: SD standard deviation
Other includes burns, diseases of the eye; female reproductive system; mental diseases & disorders; miscellaneous & ungroupable data; other reasons for
hospitalization; pregnancy & childbirth; significant trauma, injury, poisoning & toxic effects of drugs
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The introduction of PAF by the ASP was followed by
further reduction in antibiotic and PPI co-administration
compared to both the baseline and the alert cohorts.
The reduction in antibiotic administration is commen-
surate with the effectiveness of ASPs in the inpatient set-
ting [12]. Additionally, the ASP led to a reduction in PPI
administration, suggesting that it is feasible to expand
the purview of ASPs beyond solely antimicrobials. The
decrease in alert frequency following the introduction of
the ASP suggests a persistent effect on prescribing prac-
tices and cumulative benefit through enacting culture
change mediated by the ASP. Importantly, the ASP led
to a sustained reduction in the co-administration of PPIs
and antibiotics for an additional 12 months, obviating
the loss of motivation to follow alert recommendations
commonly responsible for the decreased effectiveness of
Fig. 1 Boxplot of unadjusted average monthly rates of antibiotics, proton pump inhibitors and their co-administration. Rates of co-administration
(left panel), antibiotics (middle) and proton pump inhibitors (right) during the baseline, computer alert and antibiotic stewardship program time
periods are shown. Rates are calculated as days of therapy (DOT) per 100 inpatient days whereby one DOT represents the administration of a
single medication on a given day irrespective of dosing frequency or strength. The vertical lines on either side of the point estimate encapsulate
the threshold beyond which data points are considered outliers (represented by dots). PPI = proton pump inhibitor
Fig. 2 Adjusted average monthly rates of antibiotics, proton pump inhibitors and their co-administration over time. Monthly rates of antibiotics,
PPIs, and the co-administration of antibiotics and PPIs are presented as adjusted days of therapy (DOT) per 100 inpatient days whereby one DOT
represents the administration of a single medication on a given day irrespective of dosing frequency or strength. P values for each time period
comparison (baseline-alert, alert-stewardship, and baseline-stewardship) are included. PPI = proton pump inhibitor
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electronic alerts that occurs over time [18]. ASPs should
evolve to encompass more than assessing antibiotic
appropriateness, as they are ideally situated to provide ad-
vice towards attenuating the potential harms of antibiotics,
such as decreasing PPI and antibiotic co-administration.
There are some limitations that merit emphasis.
Firstly, the short duration of observation may not accur-
ately reflect the potential benefits observed. Although
we adjusted for seasonality in our analysis, the total dur-
ation of the study was short and the CDI event rate was
low. The low CDI event rate also precluded analyzing
risk factors for CDI, including patient-related character-
istics such as age and underlying comorbidities, which
may have contributed to the absence of statistically sig-
nificant differences in CDI rates [19]. Secondly, the sin-
gle site and pre-existing comprehensive ASP, which is
activated upon the prescribing of an antibiotic for all in-
patients, may affect external validity. Thirdly, robust
measures of harm could not be collected and may be
underappreciated, especially in light of the short study
interval. Fourthly, outcomes were restricted to in-
hospital events, which may underestimate the benefit of
the interventions.
Conclusions
Reducing the co-administration of PPI’s and antibiotics
can be achieved with an automatic computerized alert
and implementation of an ASP. The computer order
entry alert facilitates enhanced awareness of drug
interactions that may curtail inappropriate medication
use. ASP mediated PAF implemented after the computer
order alert provides an opportunity to consolidate alert-
mediated changes in prescribing practices through cul-
tural change allowing for sustainability and attenuating
alert fatigue. Reproducing this study using a larger
sample size with a longer duration of follow up will
serve to test whether a reduction in PPI-antibiotic co-
administration can be sustained, the independent impact
of computer order alerts and ASP and whether the re-
duction in co-administration lowers CDI rates.
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